Impact of type 2 diabetes mellitus on results in the animal naming test in patients with and without liver cirrhosis.
<h4>Introduction and objectives</h4>Diabetes mellitus is a common comorbidity in patients with cirrhosis and is associated with the development of hepatic encephalopathy (HE) and cognitive dysfunction. The simplified Animal Naming Test (S-ANT1) has been established for detecting minimal...
Saved in:
Main Authors: | Eva Maria Schleicher, Julia Tuchscher, Matthias Weber, Peter Robert Galle, Marcus-Alexander Wörns, Simon Johannes Gairing, Christian Labenz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316490 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis
by: Christian Labenz, et al.
Published: (2025-03-01) -
Pathological Features of New Animal Models for Primary Biliary Cirrhosis
by: Koichi Tsuneyama, et al.
Published: (2012-01-01) -
DIABETES MELLITUS IN PATIENTS WITH LIVER CIRRHOSIS: NEW TREATMENT OPTIONS
by: L. Yu. Morgunov
Published: (2017-09-01) -
Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis
by: P. Priyanka, et al.
Published: (2018-01-01) -
Determining the mechanism of Shuxuening injection against liver cirrhosis through network pharmacology and animal experiments
by: Qiyao Liu, et al.
Published: (2025-01-01)